Benefits and Risks of Antihyperlipidemic Medication in Adults with Different Low-Density Lipoprotein Cholesterol Based on the Number Needed to Treat Hong-Fei WangYu-Cheng MaoQing-Bao Tian Original Research Article 23 May 2024
Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists Teresa VezzaVíctor M. Víctor Commentary 15 May 2024
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials Gustavo de Oliveira AlmeidaThiago Faraco NienkötterCamila Mota Guida Systematic Review 11 May 2024
Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials Hussain Sohail RangwalaHareer FatimaMuhammad Saqlain Mustafa Systematic Review 07 May 2024
Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study Munaza RiazJingchuan GuoHaesuk Park Original Research Article 30 April 2024 Pages: 455 - 464
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis Hasan MushahidSyeda Ayesha ShahMuhammad Shariq Usman Systematic Review 29 April 2024 Pages: 385 - 398
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China Penglei ChenYixiang WangXuwei Zheng Original Research Article 15 April 2024 Pages: 445 - 454
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis Hon Jen WongNorman H. LinChing-Hui Sia Systematic Review 08 April 2024 Pages: 371 - 383
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020 Omar S. AlkheziLeo F. BuckleyJohn Fanikos Original Research Article 07 April 2024 Pages: 433 - 444
Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis Ishaque HameedSyeda Ayesha ShahMohammad Hamza Original Research Article 05 April 2024 Pages: 419 - 431
Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis” Ioannis BellosSmaragdi MarinakiVassiliki Benetou Letter to the Editor 04 April 2024 Pages: 467 - 468
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany Alexander MichelCoralie LecomteThomas Evers Original Research Article 04 April 2024 Pages: 409 - 418
Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry Rengin Çetin GüvençTolga Sinan GüvençMehmet Birhan Yılmaz Original Research Article 04 April 2024 Pages: 399 - 408
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review Hiroaki HiraiwaTakahiro OkumuraToyoaki Murohara Review Article Open access 04 April 2024 Pages: 343 - 369
Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits Zixi ZhangCancan WangQiming Liu Review Article Open access 03 April 2024 Pages: 329 - 342
Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis” Hussain Sohail RangwalaHareer FatimaBurhanuddin Sohail Rangwala Letter to the Editor 02 April 2024 Pages: 465 - 466
Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials Andrew SephienDenisse Camille DaytoAmbuj Kumar Systematic Review 22 March 2024 Pages: 285 - 302
The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review Dora Inés Molina de SalazarAntonio CocaDaniel Piskorz Review Article Open access 15 March 2024 Pages: 197 - 209
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases Pengchen GuYuxin WuWeiwei Lu Review Article 04 March 2024 Pages: 171 - 195
Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis Ahmed Kamal SiddiqiMuhammad Talha ManiyaMuhammad Shahzeb Khan Systematic Review 28 February 2024 Pages: 273 - 284
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea Eui-Soon KimSun-Kyeong ParkSang Hong Baek Original Research Article 27 February 2024 Pages: 313 - 324
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis Mohamed Nabil ElshafeiAhmed El-BardissyMohammed Danjuma Systematic Review Open access 22 February 2024 Pages: 255 - 271
Management of Hypertension in the Asia-Pacific Region: A Structured Review Abdul R. A. RahmanJose Donato A. MagnoRohit Khurana Review Article Open access 08 February 2024 Pages: 141 - 170
Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease Jie-Jiu LuTao-Tao Liu Original Research Article 01 February 2024 Pages: 303 - 311
Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis Ioannis BellosSmaragdi MarinakiVassiliki Benetou Systematic Review Open access 01 February 2024 Pages: 241 - 253
Author’s Reply to Kow et al.: “Comparison of Clinical Outcomes between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study” Hsiu-Yu FangWei-Chieh Lee Letter to the Editor 25 January 2024 Pages: 327 - 328
Comment on: “Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study” Chia Siang KowAbdullah Faiz ZaihanSyed Shahzad Hasan Letter to the Editor 25 January 2024 Pages: 325 - 326
SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis Natnicha PoonchuaySurasak SaokaewSupatcha Incomenoy Systematic Review 22 January 2024 Pages: 211 - 240
Safety and Efficacy of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors After Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials Ahmed AtiaHeba AboeldahabAhmed Abdelaziz Systematic Review Open access 19 January 2024 Pages: 83 - 102
Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature Seyed Ali Mousavi-AghdasEbrahim FarashiNasim Naderi Review Article 29 December 2023 Pages: 19 - 37
SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know Stephen J. GreeneGregg C. FonarowJaved Butler Commentary 29 December 2023 Pages: 1 - 4
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective Andre LamyJohn Eikelboomthe COMPASS Investigators Original Research Article Open access 28 December 2023 Pages: 117 - 127
Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection Yan YuHaobin LiGuangchun Sun Original Research Article 24 December 2023 Pages: 129 - 139
Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis Mostafa Reda MostafaMohamed Magdi EidAndrew M. Goldsweig Systematic Review 23 November 2023 Pages: 71 - 81
The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review Ryaan EL-AndariNicholas M. FialkaJeevan Nagendran Systematic Review 17 November 2023 Pages: 55 - 69
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension Omnia Azmy NabehAlaa I. SaudSoha Aly Elmorsy Systematic Review Open access 09 November 2023 Pages: 39 - 54
Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies Alexander BoltonBishow PaudelDenice Hodgson-Zingman Systematic Review 19 October 2023 Pages: 103 - 115
Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study Takeshi MorimotoHaruhiko HoshinoYukihiro Koretsune Original Research Article Open access 17 October 2023 Pages: 721 - 733
Cardioprotective Strategies After Ischemia–Reperfusion Injury Honghong ZhangHuilin HuHongen Tian Review Article Open access 10 October 2023 Pages: 5 - 18
Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study Kristen Bova CampbellStephanie Dougherty EickmanJonathan P. Piccini Original Research Article 06 October 2023 Pages: 709 - 719
The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu? Theocharis KoufakisIoanna ZografouKalliopi Kotsa Current Opinion 08 September 2023 Pages: 601 - 608
Bempedoic Acid can Reduce Cardiovascular Events in Combination with Statins or As Monotherapy: A Systematic Review and Meta-analysis Ju ZhangXiangfeng GuanBo Li Systematic Review 06 September 2023 Pages: 695 - 708
The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines Luis Antonio AlcocerAlfonso BrycePablo Rodriguez Review Article Open access 05 September 2023 Pages: 663 - 682
Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy Dipti PatilLokesh Kumar Bhatt Review Article 05 September 2023 Pages: 623 - 640
Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis Tong HuYi-Han LiJing-Quan Zhong Systematic Review 28 August 2023 Pages: 683 - 694
Double Trouble: The Challenge of Neuroprotection in Patients with Liver Cirrhosis and Atrial Fibrillation Taha AhmedAdrian W. Messerli Commentary 28 August 2023 Pages: 599 - 600
SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms Yali ZhangYufeng HeJian Feng Review Article 24 August 2023 Pages: 641 - 662
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure Ilaria CavallariSimone Pasquale CrispinoFrancesco Grigioni Review Article 24 August 2023 Pages: 609 - 621
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study Jose Seijas-AmigoMª José Mauriz-MonteroInvestigadores MEMOGAL Original Research Article Open access 23 August 2023 Pages: 583 - 593